MX173379B - Proceso quimico - Google Patents

Proceso quimico

Info

Publication number
MX173379B
MX173379B MX006869A MX686986A MX173379B MX 173379 B MX173379 B MX 173379B MX 006869 A MX006869 A MX 006869A MX 686986 A MX686986 A MX 686986A MX 173379 B MX173379 B MX 173379B
Authority
MX
Mexico
Prior art keywords
formula
chemical process
compound
halogen
trifluoroalkyl
Prior art date
Application number
MX006869A
Other languages
English (en)
Inventor
Gary Thomas Borrett
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MX173379B publication Critical patent/MX173379B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a un procedimiento para la preparación de un compuesto de fórmula (I): donde Ar es un grupo: en la que X es hidrógeno, alquilo de 1-4 átomos de carbono, alcoxilo, trifluoroalquilo, hidroxilo, halógeno, metiltio, o aralquiloxilo y R3 y R4 son iguales o diferentes y cada uno es alquilo de C1-6, procedimiento que comprende la hidrogenación de un compuesto de fórmula (II): donde Ar, R3 y R4 son como se han definido para la fórmula (I) y Hal es un átomo de halógeno.
MX006869A 1985-08-10 1986-08-08 Proceso quimico MX173379B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858520154A GB8520154D0 (en) 1985-08-10 1985-08-10 Chemical process

Publications (1)

Publication Number Publication Date
MX173379B true MX173379B (es) 1994-02-23

Family

ID=10583642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX006869A MX173379B (es) 1985-08-10 1986-08-08 Proceso quimico

Country Status (10)

Country Link
US (1) US4861893A (es)
EP (1) EP0219934B1 (es)
JP (4) JPH0699389B2 (es)
CA (1) CA1290340C (es)
DE (1) DE3682253D1 (es)
ES (2) ES2000604A6 (es)
GB (1) GB8520154D0 (es)
GR (1) GR862099B (es)
MX (1) MX173379B (es)
PT (1) PT83180B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
US5446057A (en) * 1993-09-24 1995-08-29 Warner-Lambert Company Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
ES2121684B1 (es) * 1996-03-15 1999-08-16 Vita Invest Sa Procedimiento para la obtencion de (+)-cis / (+)-trans-4-(4-fluorofenil)-1-metilpiperidina-3-carboxilato de etilo.
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
EP1384720A1 (en) 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
CA2214288C (en) * 1996-09-18 2006-07-18 Lonza Ag Process for the preparation of 1-acyl-4-arylpiperidines
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
ES2329739T3 (es) * 1997-04-07 2009-11-30 Georgetown University Analogos de cocaina.
JP2002514222A (ja) 1997-05-29 2002-05-14 スミスクライン・ビーチャム・コーポレイション 新規方法
ES2155995T3 (es) 1997-06-10 2001-06-01 Synthon Bv Compuestos de 4-fenilpiperidina.
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
WO2002032870A1 (en) * 2000-10-20 2002-04-25 Smithkline Beecham P.L.C. Process of the preparation of 3-substituted-4-aryl piperidine compounds
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20080033050A1 (en) * 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE336414C (de) * 1919-06-21 1921-05-03 Chem Fab Verfahren zur Darstellung von Hexahydroderivaten der N-Methylpyridin-3-carbonsaeureester (N-Methylnicotinsaeureester)
DE574137C (de) * 1925-08-12 1933-04-10 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Piperidin und seinen Abkoemmlingen
CH369132A (de) * 1958-08-12 1963-05-15 Cilag Chemie Aktiengesellschaf Verfahren zur Herstellung von Nipecotinsäureamiden
US3922278A (en) * 1972-06-12 1975-11-25 Sterling Drug Inc 4-(3-Nitrophenyl)-3,5-pyridinedicarboxylic acid
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel

Also Published As

Publication number Publication date
EP0219934B1 (en) 1991-10-30
DE3682253D1 (de) 1991-12-05
JPH0794443B2 (ja) 1995-10-11
ES2000604A6 (es) 1988-03-01
GR862099B (en) 1986-12-30
CA1290340C (en) 1991-10-08
JPH08810B2 (ja) 1996-01-10
JPH0794442B2 (ja) 1995-10-11
PT83180B (pt) 1989-03-30
JPH07149728A (ja) 1995-06-13
JPH0699389B2 (ja) 1994-12-07
PT83180A (en) 1986-09-01
GB8520154D0 (en) 1985-09-18
JPH07138229A (ja) 1995-05-30
ES2005746A6 (es) 1989-03-16
JPH07138231A (ja) 1995-05-30
JPS6239568A (ja) 1987-02-20
EP0219934A1 (en) 1987-04-29
US4861893A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
MX173379B (es) Proceso quimico
MX171822B (es) Proceso quimico
DE3773089D1 (de) Verfahren zur herstellung von thiazolidinedion-derivaten.
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
ATE57176T1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen abkoemmlinge.
BR9907863A (pt) Composto, processo para a preparação do mesmo, composição fungicida, processo para combater fungo em um local, e, uso do composto ou da composição
KR890001955A (ko) 벤즈아미드 유도체, 그의 제조방법 및 식물성장 조절자
ES543125A0 (es) Procedimiento para preparar (r)-alfa-etil-2-oxo-1-pirrolidi-nacetamida
KR860009023A (ko) 치환된 실릴기를 갖는 신규 에테르 화합물의 제조방법
ES2037708T3 (es) Un procedimiento para preparar un derivado de bencimidazol.
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
FR2608607B1 (fr) Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
BR9813733A (pt) Processo para produção de um composto
PT80791B (pt) Processo para a preparacao de novas fenil-naftiridinas uteis nomeadamente como medicamentos anti-ulcerosos
IN162048B (es)
DE69100196T2 (de) Verfahren zur Herstellung von Benzylaminen.
ES524363A0 (es) Procedimiento para la preparacion de 7 -aciltio-15,16-metilen-3-oxo-17 -pregna-1,4-dien-21,17-carbolactonas
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
AR240813A2 (es) N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento
ATE46322T1 (de) Verfahren zur herstellung von bestatin-derivaten und deren zwischenprodukte.
ATE47592T1 (de) Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen.
ATE70269T1 (de) Verfahren zur herstellung von 2-carboxypyrazin-4- oxiden.
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
DE3660959D1 (de) Benz-trisubstituted 2-aminotetralins